BSC Buys Target; Sulzer Medica Spins Off
Executive Summary
For the last couple of years, one of the most closely-watched battles in the medical device industry was that between Target Therapeutics Inc., with 1996 sales of $47.5mm, and its much larger competitors, Boston Scientific Corp. and Johnson & Johnson in the struggle for the market for miniature catheters used in minimally-invasive applications, particularly interventional neurology.